PRQR logo

ProQR Therapeutics NV (PRQR) Free Cash Flow

Annual FCF

$21.84 M
+$94.84 M+129.93%

December 31, 2023


Summary


Performance

PRQR Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRcash flowmetrics:

Quarterly FCF

-$7.05 M
-$178.60 K-2.60%

September 1, 2024


Summary


Performance

PRQR Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRcash flowmetrics:

TTM FCF

-$37.73 M
+$1.55 M+3.94%

September 1, 2024


Summary


Performance

PRQR TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PRQR Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+129.9%+18.0%-624.1%
3 y3 years+139.9%+48.4%+20.9%
5 y5 years+164.2%+48.4%+20.9%

PRQR Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+129.9%-114.7%+69.7%-272.7%+48.3%
5 y5-yearat high+129.9%-114.7%+69.7%-272.7%+48.3%
alltimeall timeat high+129.9%-114.7%+69.7%-272.7%+48.3%

ProQR Therapeutics NV Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.05 M(+2.6%)
-$37.73 M(-3.9%)
Jun 2024
-
-$6.87 M(-60.1%)
-$39.28 M(-9.2%)
Mar 2024
-
-$17.23 M(+162.1%)
-$43.28 M(-298.1%)
Dec 2023
$21.84 M(-129.9%)
-$6.57 M(-23.5%)
$21.84 M(+203.4%)
Sep 2023
-
-$8.60 M(-20.9%)
$7.20 M(+236.1%)
Jun 2023
-
-$10.87 M(-122.7%)
$2.14 M(-214.9%)
Mar 2023
-
$47.89 M(-325.7%)
-$1.86 M(-97.4%)
Dec 2022
-$72.99 M(+132.8%)
-$21.22 M(+55.4%)
-$72.99 M(+53.1%)
Sep 2022
-
-$13.66 M(-8.2%)
-$47.69 M(+10.5%)
Jun 2022
-
-$14.88 M(-36.0%)
-$43.17 M(+6.9%)
Mar 2022
-
-$23.24 M(-668.5%)
-$40.38 M(+28.8%)
Dec 2021
-$31.35 M(-42.8%)
$4.09 M(-144.7%)
-$31.35 M(-34.7%)
Sep 2021
-
-$9.14 M(-24.4%)
-$48.01 M(-8.4%)
Jun 2021
-
-$12.09 M(-14.9%)
-$52.43 M(+0.4%)
Mar 2021
-
-$14.21 M(+13.0%)
-$52.23 M(-4.7%)
Dec 2020
-$54.80 M(+9.9%)
-$12.57 M(-7.2%)
-$54.80 M(-2.4%)
Sep 2020
-
-$13.55 M(+13.9%)
-$56.12 M(+7.7%)
Jun 2020
-
-$11.89 M(-29.1%)
-$52.09 M(-0.5%)
Mar 2020
-
-$16.78 M(+20.7%)
-$52.35 M(+5.0%)
Dec 2019
-$49.87 M
-$13.90 M(+46.0%)
-$49.87 M(+5.9%)
Sep 2019
-
-$9.52 M(-21.7%)
-$47.11 M(+11.7%)
Jun 2019
-
-$12.16 M(-15.0%)
-$42.18 M(+15.9%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$14.30 M(+28.4%)
-$36.38 M(+7.0%)
Dec 2018
-$34.01 M(-14.4%)
-$11.13 M(+142.8%)
-$34.01 M(+7.6%)
Sep 2018
-
-$4.59 M(-27.9%)
-$31.62 M(-15.5%)
Jun 2018
-
-$6.36 M(-46.7%)
-$37.41 M(-11.4%)
Mar 2018
-
-$11.93 M(+36.5%)
-$42.25 M(+6.4%)
Dec 2017
-$39.72 M(-2.4%)
-$8.75 M(-15.7%)
-$39.72 M(+2.2%)
Sep 2017
-
-$10.38 M(-7.3%)
-$38.86 M(-4.6%)
Jun 2017
-
-$11.19 M(+19.0%)
-$40.75 M(-0.5%)
Mar 2017
-
-$9.40 M(+19.3%)
-$40.97 M(+0.7%)
Dec 2016
-$40.68 M(+43.5%)
-$7.88 M(-35.8%)
-$40.68 M(+0.4%)
Sep 2016
-
-$12.27 M(+7.5%)
-$40.51 M(+14.6%)
Jun 2016
-
-$11.41 M(+25.1%)
-$35.35 M(+14.1%)
Mar 2016
-
-$9.12 M(+18.3%)
-$30.98 M(+9.2%)
Dec 2015
-$28.36 M(+35.9%)
-$7.71 M(+8.6%)
-$28.36 M(+0.7%)
Sep 2015
-
-$7.10 M(+0.8%)
-$28.17 M(+4.4%)
Jun 2015
-
-$7.04 M(+8.3%)
-$26.97 M(+10.1%)
Mar 2015
-
-$6.50 M(-13.5%)
-$24.50 M(+17.4%)
Dec 2014
-$20.87 M(+536.3%)
-$7.52 M(+27.4%)
-$20.87 M(+56.3%)
Sep 2014
-
-$5.90 M(+28.9%)
-$13.35 M(+79.3%)
Jun 2014
-
-$4.58 M(+59.7%)
-$7.44 M(+159.7%)
Mar 2014
-
-$2.87 M
-$2.87 M
Dec 2013
-$3.28 M
-
-

FAQ

  • What is ProQR Therapeutics NV annual free cash flow?
  • What is the all time high annual FCF for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual FCF year-on-year change?
  • What is ProQR Therapeutics NV quarterly free cash flow?
  • What is the all time high quarterly FCF for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly FCF year-on-year change?
  • What is ProQR Therapeutics NV TTM free cash flow?
  • What is the all time high TTM FCF for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV TTM FCF year-on-year change?

What is ProQR Therapeutics NV annual free cash flow?

The current annual FCF of PRQR is $21.84 M

What is the all time high annual FCF for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual free cash flow is $21.84 M

What is ProQR Therapeutics NV annual FCF year-on-year change?

Over the past year, PRQR annual free cash flow has changed by +$94.84 M (+129.93%)

What is ProQR Therapeutics NV quarterly free cash flow?

The current quarterly FCF of PRQR is -$7.05 M

What is the all time high quarterly FCF for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly free cash flow is $47.89 M

What is ProQR Therapeutics NV quarterly FCF year-on-year change?

Over the past year, PRQR quarterly free cash flow has changed by +$1.55 M (+17.99%)

What is ProQR Therapeutics NV TTM free cash flow?

The current TTM FCF of PRQR is -$37.73 M

What is the all time high TTM FCF for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high TTM free cash flow is $21.84 M

What is ProQR Therapeutics NV TTM FCF year-on-year change?

Over the past year, PRQR TTM free cash flow has changed by -$44.93 M (-624.15%)